Newsfeeds - Spark Newswire

2 minute read

Two Major Psychedelics Companies Take Novel Chemical Entity Patent Battle To Federal Court

Today, 11:23 PM

Clinical-stage biopharma company Reunion Neuroscience Inc. (NASDAQ: REUN) filed a lawsuit against drug discovery business Mindset Pharma Inc. (OTCQB: MSSTF) in the District Court of New Jersey.

MSSTF

5 minute read

Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More

By Lara Goldstein

Today, 11:23 PM

Major Depressive Disorder: Small Pharma’s Phase 2 DMT Trial, BetterLife’s Preclinical LSD Trial

ATAI

2 minute read

Silo Pharma, Mindset Pharma, Terran Biosciences Receive Psychedelic Treatments Patents, IP Portfolios Expanded

By Lara Goldstein

Today, 11:23 PM

Silo Pharma Sees Growth In IP With New US Patent For Novel Ketamine Method On Stress-Induced Affective Disorders

MSSTF

4 minute read

Psyched: States With Psychedelics Legalization Bills, Next-Gen Molecule For Addiction Treatment And More

By Lara Goldstein

Today, 11:23 PM

Legalizing Psychedelics From New York To Washington And Five In Between: Which State Will Go First?

CLABF

2 minute read

Search Is On For Psychedelic Patents & FDA Designations, 3 Companies Share News

By Lara Goldstein

Today, 11:23 PM

Drug discovery company Mindset Pharma (OTCQB: MSSTF) has been greenlighted by the US Patent and Trademark Office (USPTO) on its application “Psilocin Derivatives As Serotonergic Psychedelic Agents for the Treatment of CNS Disorders.”

MSSTF

6 minute read

Psyched: Musk’s Empathy Tweets, Psychedelics In Congress, Oregon’s Opt-Outs, MAPS’ MDMA Trial And More

By Lara Goldstein

Today, 11:23 PM

Elon Musk Joins Twitter Conversation Around Psychedelics: A Debate On Empathy

AGNPF

4 minute read

EXCLUSIVE: Insider’s Peek At Mammoth Of Psychedelics VCs, Palo Santo, Market Subverticals & Informal Guidance

By Lara Goldstein

Today, 11:23 PM

(Part four of a four-part series) See previous stories in this series:

ATAI

4 minute read

Psyched: CA’s Psychedelic-Assisted Treatments, Ketamine Therapy, Near-Death Experience And More

By Lara Goldstein

Today, 11:23 PM

Alberta Becomes The First Canadian Province To Regulate Psychedelics-Assisted Therapy

ATAI

2 minute read

Cybin Acquires Exclusive License To Mindset Pharma’s Tryptamine Compounds Family

By Lara Goldstein

Today, 11:23 PM

Through its wholly-owned subsidiary, Cybin IRL Limited, Canadian-based psychedelics biotech Cybin Inc. (NYSE AMERICAN: CYBN) signed an agreement with next-gen psychedelics producer Mindset Pharma Inc.

CYBN

1 minute read

Psychedelics Companies Explore & Protect Their Findings, This Firm Is Doing That In 16 Countries

By Lara Goldstein

Today, 11:23 PM

Psychedelics R&D company Mindset Pharma (OTCQB: MSSTF) has filed no less than 16 national applications, including countries within the main South East Asian markets, for one of its key families of next-generation psychedelic compounds.

MSSTF